1-3 of 3
Trudy Straetemans
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR

Moniek de Witte, Jojanneke Scheepstra, Naomi Weertman, Annet Daudeij, Lotte van der Wagen, Rimke Oostvogels, Colin de Haar, Henk-Jan Prins, Willem Dohmen, Carly Bartels-Wilmer, Inez Johanna, Zsolt Sebestyen, Jurgen Kuball, Trudy Straetemans
Journal: Blood
Blood (2022) 140 (Supplement 1): 12737–12739.
https://doi.org/10.1182/blood-2022-158191
Published: 2022
Journal Articles

Towards the Next Generation CAR T Cells with TEGs: In Vivo Efficacy — Toxicity Profile in Xenografts of Primary Human AML Disease and Healthy Bone Marrow

Trudy Straetemans, PhD, Inez Johanna Gan, MSc, Sabine Heijhuurs, MSc, Guido Kierkels, MSc, Koen Jansen, BSc, Ruud Doorn, BSc, Tineke Aarts, BSc, Haakan Norrel, PhD, Zsolt Sebestyen, PhD, Jurgen Kuball, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3336.
https://doi.org/10.1182/blood.V130.Suppl_1.3336.3336
Published: 2017
Journal Articles

γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs

Cordula Gründer, Suzanne van Dorp, Samantha Hol, Esther Drent, Trudy Straetemans, Sabine Heijhuurs, Kirsten Scholten, Wouter Scheper, Zsolt Sebestyen, Anton Martens, Roland Strong, Jürgen Kuball
Journal: Blood
Blood (2012) 120 (26): 5153–5162.
https://doi.org/10.1182/blood-2012-05-432427
Published: 2012
Includes: Supplemental data